Browse by author
Lookup NU author(s): Dr Kanthimathin Sankar
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Successful treatment of gonorrhoea is the mainstay of public health control. Cefixime and ceftriaxone, highly active third generation cephalosporins, are today the recommended first-line agents in most countries and azithromycin is a second-line agent. However, there is increasing evidence of decreasing susceptibility and emergence of therapeutic failures. In this report two cases of clinical failure to cefixime are described, one of which additionally shows failure to azithromycin and selection of a less susceptible strain during treatment.
Author(s): Ison CA, Hussey J, Sankar KN, Evans J, Alexander S
Publication type: Article
Publication status: Published
Journal: Eurosurveillance
Year: 2011
Volume: 16
Issue: 14
Pages: 7-10
Print publication date: 01/04/2011
ISSN (print): 1025-496X
ISSN (electronic): 1560-7917
Publisher: Centre Europeen pour la Surveillance Epidemiologique du SIDA
URL: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19833